Glutamate does not play a major role in controlling bone growth

Area of Science:

• Bone biology
• Neuroscience
• Cell signaling

Background:

• Bone cells express N-methyl-D-aspartate (NMDA) receptors and glutamate transporters (GLAST).
• Glutamate signaling is crucial in the brain; its role in bone homeostasis is hypothesized.
• Mechanical loading affects GLAST expression, suggesting glutamate's potential influence on bone metabolism.

Purpose of the Study:

• To investigate the role of glutamate signaling in bone formation and resorption.
• To determine if NMDA receptor activation or blockade affects osteoblast and osteoclast activity.
• To assess the impact of glutamate transporter GLAST knockout on bone development and structure.

Main Methods:

• In vitro studies using rat osteoblasts and osteoclasts treated with NMDA receptor agonists/antagonists (MK-801, AP-5).
• Assessment of bone resorption pits and bone formation markers.
• Analysis of bone size, morphology, and cellular activity in GLAST knockout mice compared to wild-type siblings.

Main Results:

• NMDA receptor modulation did not affect osteoblast bone formation.
• MK-801 reduced osteoclast resorption pits, but AP-5 did not, indicating a non-glutamate-specific effect.
• GLAST knockout mice showed no significant differences in bone structure or remodeling compared to controls.

Conclusions:

• Glutamate does not appear to be a major intercellular messenger controlling bone formation or resorption.
• The observed effects of MK-801 on osteoclasts are likely independent of its NMDA receptor antagonism.
• Glutamate signaling pathways are unlikely to be significant targets for therapeutic intervention in bone diseases.